By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Ionis Pharmaceuticals 

2855 Gazelle Court

Carlsbad  California  92010  U.S.A.
Phone: 760-931-9200 Fax: n/a


Ionis Pharmaceuticals, Inc., located in the North San Diego County city of Carlsbad, was founded in 1989 to create advanced, novel medicines to treat complex and challenging diseases. We are the pioneer in the discovery and development of antisense drugs with more than 1300 patents.

Ionis is a challenging, motivating and rewarding environment designed to foster innovation and scientific excellence. Our founding goals have changed little in over 27 years and our success is a direct result of our outstanding employees. We are interested in bringing together individuals with different skill sets into this creative environment to be part of a productive team. Join us and experience our unique culture while you develop and expand your career.

See Collaborations

Key Statistics

Ownership: Public

Web Site: Ionis Pharma
Employees: 400+
Symbol: IONS


Company News
Akcea Therapeutics And Ionis Pharma (IONS) Announce Filing Of New Drug Submission For Volanesorsen To Health Canada 9/13/2017 7:28:30 AM
Ionis Pharma (IONS) Release: New Data Presented At European Society For Medical Oncology Meeting Demonstrate Antitumor Activity With IONIS-STAT3-2.5 Rx In Combination With Imfinzi 9/11/2017 8:42:27 AM
Akcea Therapeutics And Ionis Pharma (IONS) Announce Submission Of New Drug Application For Volanesorsen To The FDA 8/31/2017 10:58:30 AM
Ionis Pharma (IONS) Earns $40 Million SPINRAZA Regulatory Milestone Payment From Biogen (BIIB) 8/30/2017 7:00:01 AM
Ionis Pharma (IONS) Urges Investors to Reject the Below-the-Market Offer By TRC Capital 8/24/2017 5:34:38 AM
GlaxoSmithKline (GSK) Ditches Ionis Pharma (IONS)'s Inotersen and IONIS-FB-LRx 8/11/2017 7:10:11 AM
Ionis Pharma (IONS) Provides Improved 2017 Guidance Following Strong Financial Performance 8/8/2017 12:22:52 PM
Akcea Therapeutics And Ionis Pharma (IONS) Announce Submission Of Marketing Authorization Application For Volanesorsen To The EMA 7/27/2017 6:35:00 AM
Ionis Pharma (IONS) To Hold Second Quarter 2017 Financial Results Webcast 7/25/2017 11:36:43 AM
Ionis Pharma (IONS) Earns $10 Million Milestone Payment From Biogen (BIIB) For Advancing A New Program In Its Neurology Collaboration 7/17/2017 8:05:17 AM